Author:
Hacisahinogullari Hulya,Tekin Sakin,Tanrikulu Seher,Saribeyliler Goktug,Yalin Gulsah Yenidunya,Bilgic Bilge,Isik Emine Goknur,Salduz Ahmet,Tuncer Samuray,Gul Nurdan,Uzum Ayse Kubat,Aral Ferihan,Tanakol Refik,Selcukbiricik Ozlem Soyluk
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. J. Amanzadeh, R.F. Reilly Jr, Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat. Clin. Pract. Nephrol. 2(3), 136–148 (2006). https://doi.org/10.1038/ncpneph0124
2. P. Florenzano, I.R. Hartley, M. Jimenez et al. Tumor-induced osteomalacia. Calcif. Tissue Int. 108(1), 128–142 (2021). https://doi.org/10.1007/s00223-020-00691-6
3. J.E. Blau, M.T. Collins, The PTH-Vitamin D-FGF23 axis. Rev. Endocr. Metab. Disord. 16(2), 165–174 (2015). https://doi.org/10.1007/s11154-015-9318-z
4. R.A. McCance, Osteomalacia with Looser’s nodes (Milkman’s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q. J. Med. 16(1), 33–46 (1947)
5. A. Prader, R. Illig, E. Uehlinger et al. Rickets following bone tumor. Helv. Paediatr. Acta 14, 554–565 (1959)